The French government has reversed an earlier ban on hydroxychloroquine for treating COVID19 patients.
The ban was reversed in light of successful clinical studies showing significant efficacy against the virus.
Hydroxychloroquine may now be prescribed to treat COVID-19 in France, according to the government.
Earlier this month Australian researchers said some Covid-19 patients have responded ‘very well’ to drugs used to treat malaria.
A team of infectious disease experts at the University of Queensland in Brisbane revealed that the medication helped to wipe out COVID-19 infections.
Chloroquine, an anti-malarial drug works in a different way and is given to people to prevent malaria infections if they are bitten by a mosquito carrying the parasite.
The drug works by salts inside them poisoning parasites and preventing them from growing inside human red blood cells.
India, Hungary & the United Kingdom have all banned export of the drug to save supply for themselves.
Jordan and France authorized use of hydroxychloroquine to treat COVID-19 while Bahrain claims success with drug on coronavirus patients.
BREAKING: French government reverses earlier ban on hydroxychloroquine for treating COVID19 patients in light of successful clinical studies showing significant efficacy against the virus.
Hydroxychloroquine may now be prescribed to treat COVID-19 in France.
— Michael Coudrey (@MichaelCoudrey) March 28, 2020
Meanwhilel scientists all over the world are still racing to secure a vaccine for the coronavirus.
In the United States, the clinical trial evaluating a vaccine designed to protect against the new coronavirus has started.
According to officials there’s no chance participants could get infected from the shots, since they don’t contain the virus itself.
The goal is purely to check that the vaccines show no worrisome side effects, setting the stage for larger tests.
But health officials say it will take a year to 18 months to fully validate any potential vaccine.
Source: Africafeeds.com
